Ridgeback Capital is a New York City, New York based investment firm. They seek investments in healthcare and life science sectors.They make long term investments in private and public companies Ridgeback Capital feels are dedicated to developing life saving and life changing therapies with which they feel patient capital is vital.
Ridgeback Capital has invested in Harpoon Therapeutics, 4D Molecular Therapeutics, Precision BioSciences, Selecta Biosciences, Adaptimmune, Bellicum Pharmaceuticals, Stem Cell Therapeutics, Microbia, Alveolus and Nested.
Ridgeback Capital has exited from investments in Precision BioSciences, Adaptimmune, Harpoon Therapeutics, Selecta Biosciences, Bellicum Pharmaceuticals, Stem Cell Therapeutics, Microbia and Alveolus.
Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products.
Dr. Wayne Holman